You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-CD38 antibody [AT13/5] (ab34283)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CD38 antibody [AT13/5]
See all CD38 products (40) ...

Description

Mouse monoclonal [AT13/5] to CD38

Tested applications

Flow Cyt, IHC-Fr, IPmore details

Cross reactivity

Reacts with

Human

Immunogen

The details of the immunogen for this antibody are not available.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.09% Sodium Azide
Constituents: Tris buffered saline

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Monoclonal

Clone number

AT13/5

Myeloma

NS1

Isotype

IgG1

Applications

Show applications key

Our Abpromise guarantee covers the use of ab34283 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Flow Cyt

     
  • IHC-Fr

     
  • IP

     

Application notes

Flow Cyt: Use at 1/100. Use 10µl of this dilution for 106 cells in 100µl.
IHC-Fr: Use at an assay dependent dilution.
IP: Use at an assay dependent dilution.

Is unsuitable for IHC-P.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Synthesizes cyclic ADP-ribose, a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system.

Tissue specificity

Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma.

Sequence similarities

Belongs to the ADP-ribosyl cyclase family.

Developmental stage

Preferentially expressed at both early and late stages of the B and T-cell maturation. It is also detected on erythroid and myeloid progenitors in bone marrow, where the level of surface expression was shown to decrease during differentiation of blast-forming unit E to colony-forming unit E.

Cellular localization

Membrane.

Target information above from: UniProt accessionP28907 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Form

There are 2 isoforms produced by alternative splicing.

Alternative names

  • Acute lymphoblastic leukemia cells antigen CD38 antibody
  • ADP ribosyl cyclase 1 antibody
  • ADP ribosyl cyclase antibody
  • ADP ribosyl cyclase/cyclic ADP-ribose hydrolase antibody
  • ADP-ribosyl cyclase 1 antibody
  • CADPr hydrolase 1 antibody
  • CD 38 antibody
  • CD38 antibody
  • CD38 antibody
  • CD38 antigen (p45) antibody
  • CD38 antigen antibody
  • CD38 molecule antibody
  • Cd38-rs1 antibody
  • CD38_HUMAN antibody
  • CD38H antibody
  • Cyclic ADP ribose hydrolase 1 antibody
  • Cyclic ADP ribose hydrolase antibody
  • Cyclic ADP-ribose hydrolase 1 antibody
  • EC 3.2.2.5 antibody
  • Ecto nicotinamide adenine dinucleotide glycohydrolase antibody
  • I-19 antibody
  • I19 (mouse) antibody
  • Lymphocyte differentiation antigen CD38 antibody
  • NAD(+) nucleosidase antibody
  • NIM-R5 antigen antibody
  • NIMR5 antigen (mouse) antibody
  • OTTHUMP00000158633 antibody
  • OTTHUMP00000217743 antibody
  • p45 antibody
  • T10 antibody
see all

References for Anti-CD38 antibody [AT13/5] (ab34283)

ab34283 has not yet been referenced specifically in any publications.

Publishing research using ab34283? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"